Development and testing of MRI-mediated radiofrequency ablation system and probes

MRI介导的射频消融系统和探头的开发和测试

基本信息

  • 批准号:
    9200285
  • 负责人:
  • 金额:
    $ 74.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-09-05 至 2018-08-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract Radiofrequency ablation (RFA) is a minimally invasive method used to treat solid tumors, commonly primary liver cancers and metastases, which are accessible percutaneously via a sharp needle. Imaging guidance, typically by ultrasound or CT, is required for probe placement, but these methods are incapable of monitoring the progress of the procedure. Additional imaging sessions are required to initially locate the tumor and to assess the effectiveness of the therapy. The overall goal of this project is to translate into clinical practice a novel MRI-mediated RFA therapy. In this method, RF energy is provided and controlled by the MRI scanner, eliminating the need for an external RF generator and a grounding pad. The MRI scanner additionally offers superior soft tissue contrast for tumor localization and real time guidance of RF probe placement using a commercial gradient-based navigation system. Additionally, monitoring of tissue (rather than probe) temperature is possible during the procedure, permitting immediate assessment of the success of the ablation. Eliminating the grounding pad reduces the possibility of patient burns, and therefore increases patient safety. An initial R21 exploratory grant funded basic discovery research into this technology, comprising theoretic, scientific and technical development of MRI-mediated RFA, resulting in the demonstration of proof of principle in phantoms, tissue specimens, animal cadavers and live animals. The purpose of the current project is to translate these basic findings into a safe and practical system for clinical use, and to conduct a human clinical pilot project to assess if a full clinical trial is warranted. Specific aims include: 1- Develop integrated biopsy and RFA probes for MRI-mediated RF ablation. 2 - Optimize the performance of MRI-mediated RFA in phantom study. 3 - Optimize performance and safety of MRI-mediated biopsy and RFA in an animal study. 4 - Conduct the required regulatory activities needed to enable human study of the system. 5 - Perform pilot study in humans with liver cancer to be treated by chemotherapy. The long term goal of the research is to develop a time-efficient, cost-effective, minimally invasive “one-stop shop” treatment for solid tumors treatable by thermal ablation. If successful, it will provide a powerful diagnostic and therapeutic tool that can be used on any MRI scanner with low cost disposable devices and without the need to add major external apparatus. This is expected to facilitate the use of MRI-guided RFA to treat a wide range of tumors as a replacement for more invasive and more costly surgical management, contributing to the PHS mission of improving health care delivery while reducing cost and patient discomfort.
项目总结/文摘

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JEROME L ACKERMAN其他文献

JEROME L ACKERMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JEROME L ACKERMAN', 18)}}的其他基金

Bone Quality Assessment with a Novel Three-Bore Magnet Extremity MRI Scanner
使用新型三孔磁铁肢体 MRI 扫描仪进行骨质量评估
  • 批准号:
    10092957
  • 财政年份:
    2020
  • 资助金额:
    $ 74.91万
  • 项目类别:
Bone Quality Assessment with a Novel Three-Bore Magnet Extremity MRI Scanner
使用新型三孔磁铁肢体 MRI 扫描仪进行骨质量评估
  • 批准号:
    10318986
  • 财政年份:
    2020
  • 资助金额:
    $ 74.91万
  • 项目类别:
Bone Quality Assessment with a Novel Three-Bore Magnet Extremity MRI Scanner
使用新型三孔磁铁肢体 MRI 扫描仪进行骨质量评估
  • 批准号:
    9885138
  • 财政年份:
    2020
  • 资助金额:
    $ 74.91万
  • 项目类别:
Moving MRI: Imaging a Moving Body with a Moving MRI Magnet
移动 MRI:使用移动 MRI 磁体对移动的身体进行成像
  • 批准号:
    10007118
  • 财政年份:
    2020
  • 资助金额:
    $ 74.91万
  • 项目类别:
Employing Magnetic Vestibular Stimulation (MVS) during Functional Imaging
在功能成像期间采用磁前庭刺激 (MVS)
  • 批准号:
    9126109
  • 财政年份:
    2016
  • 资助金额:
    $ 74.91万
  • 项目类别:
15T Ultrahigh Field Horizontal MR Microscope for Mouse Imaging
用于小鼠成像的 15T 超高视场水平磁共振显微镜
  • 批准号:
    7126118
  • 财政年份:
    2006
  • 资助金额:
    $ 74.91万
  • 项目类别:
15T ULTRAHIGH FIELD HORIZONTAL MR MICROSCOPE FOR MOUSE IMAGING: ORTHOPAEDICS
用于小鼠成像的 15T 超高视场水平磁共振显微镜:骨科
  • 批准号:
    7335324
  • 财政年份:
    2006
  • 资助金额:
    $ 74.91万
  • 项目类别:
15T ULTRAHIGH FIELD HORIZONTAL MR MICROSCOPE FOR MOUSE IMAGING: CARDIOVASCULAR
用于小鼠成像的 15T 超高场水平磁共振显微镜:心血管
  • 批准号:
    7335321
  • 财政年份:
    2006
  • 资助金额:
    $ 74.91万
  • 项目类别:
15T ULTRAHIGH FIELD HORIZONTAL MR MICROSCOPE FOR MOUSE IMAGING: NEUROSCIENCE
用于小鼠成像的 15T 超高场水平磁共振显微镜:神经科学
  • 批准号:
    7335322
  • 财政年份:
    2006
  • 资助金额:
    $ 74.91万
  • 项目类别:
15T ULTRAHIGH FIELD MR MICROSCOPE FOR MOUSE IMAGING: TISSUE ENGINEERING
用于小鼠成像的 15T 超高场磁共振显微镜:组织工程
  • 批准号:
    7335323
  • 财政年份:
    2006
  • 资助金额:
    $ 74.91万
  • 项目类别:

相似海外基金

EVALUATION OF IOWA CANCER REGISTRY DATA LINKAGE WITH AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) CANCERLINQ. POP 9/10/19 - 9/9/20.
评估爱荷华州癌症登记处与美国临床肿瘤学会 (ASCO) CANCERLINQ 的数据链接。
  • 批准号:
    10026959
  • 财政年份:
    2019
  • 资助金额:
    $ 74.91万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了